Brief: Spectral Medical Inc. Closes C$6.1 Million 'Bought Deal' Convertible Note Financing
07/09/2023 13:01
Sept 7 (Reuters) - SPECTRAL MEDICAL EDT.TO :
* SPECTRAL MEDICAL INC. CLOSES C$6.1 MILLION BOUGHT DEAL
CONVERTIBLE NOTE FINANCING
* SPECTRAL MEDICAL INC - INTENDS TO USE NET PROCEEDS FROM
OFFERING
FOR ITS PHASE III REGISTRATION TRIAL (TIGRIS STUDY) FOR ITS PMX
PRODUCT TREATMENT
* SPECTRAL MEDICAL INC - REMAINS ON TRACK TO REACH IMPORTANT
INTERIM MILESTONE OF 90 PATIENTS ENROLLED BY END OF 2023 IN
TIGRIS STUDY
Source text for Eikon: ID:nGNX60q33g
Further company coverage: EDT.TO
(Reporting by ArsheeyaSingh Bajwa)
((ArsheeyaSingh.Bajwa@thomsonreuters.com;))
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%